Signature Resources Capital Management, LLC Recursion Pharmaceuticals, Inc. Transaction History
Signature Resources Capital Management, LLC
- $116 Billion
- Q1 2025
A detailed history of Signature Resources Capital Management, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Signature Resources Capital Management, LLC holds 38 shares of RXRX stock, worth $209. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38
Previous 38
-0.0%
Holding current value
$209
Previous $257,000
21.79%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
343Shares Held
285MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$187 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$178 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$137 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$95.4 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$80.8 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $994M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...